Print

Mark Grossien

Mark Grossien
Vice-Chair, IGBA International External Engagements Committee 

Head of Strategic Communications
Sandoz

Mark Grossien is the Head of Strategic Communications at Sandoz, a global leader in generic and biosimilar medicines. In this role, he oversees the worldwide communications strategies for the company's Development, Commercial & Operations, Manufacturing and Supply, and Technology organizations. Mark joined Sandoz in 2023.

He has over 12 years of senior experience at Novartis, where he held executive communications roles at global, regional, and country levels. His early career includes leadership positions in marketing, government affairs, and communications at HARTMANN Group, MedTech Europe, and various PR agencies.

Mark holds a master’s degree in communications from the University of Mainz, Germany, and American University in Washington, D.C. He is also a Fulbright Scholar. Before embarking on his academic career, Mark served as an Emergency Medical Technician with the German Red Cross. With more than 20 years in corporate affairs, he has worked in Belgium, Germany, Japan, Switzerland, and the USA. Mark is currently based in Basel, Switzerland.

Share this page!

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

E-mail: 
This email address is being protected from spambots. You need JavaScript enabled to view it.  

Follow us on: Twitter - LinkedIn - YouTube

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site